Arkolith/Insider Trading/CDMO/Form 4

Hart Daniel R

Chief Financial OfficerAvid Bioservices, Inc. (CDMO) · full profile →Form 4 · filed Dec 27, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$279K
Net Open-Market Flow
-$279K
Transactions
11
4 non-derivative · 7 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 26, 2024Sell(S)21K$12.22$255K111K
Dec 26, 2024Sell(S)2K$12.22$24K132K
Dec 25, 2024Option exercise(M)45K——134K
Dec 25, 2024Option exercise(M)4K——88K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 25, 2024Disposed to issuer(D)23K—$0140K
Dec 25, 2024Disposed to issuer(D)4K—$0123K
Dec 25, 2024Disposed to issuer(D)11K—$0196K
Dec 25, 2024Disposed to issuer(D)11K—$0185K
Dec 25, 2024Disposed to issuer(D)11K—$0174K
Dec 25, 2024Disposed to issuer(D)11K—$0162K
Dec 25, 2024Disposed to issuer(D)23K—$0117K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001683168-24-009024) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML